Search

Your search keyword '"Jacoby, Meagan A."' showing total 37 results

Search Constraints

Start Over You searched for: Author "Jacoby, Meagan A." Remove constraint Author: "Jacoby, Meagan A." Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
37 results on '"Jacoby, Meagan A."'

Search Results

7. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need

8. Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning Regimen

10. Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

12. Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study

13. Phase I Study of Baricitinib Gvhd Prophylaxis in HLA-Matched, Peripheral Blood Allogeneic Hematopoietic Cell Transplant

14. 386 - A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

15. Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

23. Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes

26. Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

27. Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

28. Safety, Efficacy, and Determination of the Recommended Phase 2 Dose for the Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330)

Catalog

Books, media, physical & digital resources